Persistence and adherence of solifenacin treatment for Japanese women with overactive bladder

Persistence and adherence of overactive bladder (OAB) medication have reported to be generally lower in real-world setting as compared with those in clinical trials. However, this information in Japanese population has not been well addressed. Medical records were reviewed for solifenacin as an init...

Full description

Bibliographic Details
Published in:	Urogynaecologia International Journal
Main Authors:	Minoru Kobayashi, Akinori Nukui, Shinsuke Kurokawa, Tatsuo Morita
Format:	Article
Language:	English
Published:	PAGEPress Publications 2012-10-01
Subjects:	adherence overactive bladder persistence solifenacin.
Online Access:	http://www.urogynaecologia.org/index.php/uij/article/view/141

Similar Items

Efficacy of Combined Therapy With Silodosin and Solifenacin in Females With Overactive Bladder
by: Byeong Jo Jeon, et al.
Published: (2024-12-01)

Efficacy and safety of solifenacin for overactive bladder: An updated systematic review and meta-analysis
by: I Gede Yogi Prema Ananda, et al.
Published: (2025-01-01)

Efficacy and Tolerability of Solifenacin Fumarate with Overactive Bladder Patients: A Multicenter Observational Study
by: Jae Hun Shim, et al.
Published: (2021-04-01)

Clinical Factors Associated With Dose Escalation of Solifenacin for the Treatment of Overactive Bladder in Real Life Practice
by: Ji-Youn Chun, et al.
Published: (2014-03-01)

Efficacy and safety of solifenacin combined with biofeedback in children with overactive bladder
by: Yan Hu, et al.
Published: (2024-04-01)

Effect of electroacupuncture versus solifenacin for moderate and severe overactive bladder: a multi-centre, randomized controlled trial study protocol
by: Qian Wen, et al.
Published: (2020-07-01)

Predictors of non-persistence in women with overactive bladder syndrome
by: Sheng-Mou Hsiao
Published: (2024-03-01)

Meta-Analysis of the Efficacy and Safety of Mirabegron Add-On Therapy to Solifenacin for Overactive Bladder
by: Yankai Xu, et al.
Published: (2017-09-01)

Regular and Irregular Use and Reasons for Discontinuation of Solifenacin Therapy in Patients with Overactive Bladder Managed by Urologists
by: Mateusz Małkowski, et al.
Published: (2024-01-01)

THE EFFICACY COMPARISON OF MIRABEGRON AS A MONOTHERAPY VERSUS ITS COMBINATION WITH SOLIFENACIN IN OVERACTIVE BLADDER: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
by: Hasan Madani, et al.
Published: (2021-07-01)

Solifenacin versus posterior tibial nerve stimulation for overactive bladder in patients with multiple sclerosis
by: Nastaran Majdinasab, et al.
Published: (2023-02-01)

Comparison Of Outcome And Side Effects Profile Of Treatment Of Overactive Bladder With Different Classes Of Drugs
by: Nazish Sarfraz, et al.
Published: (2023-12-01)

Therapeutic effectiveness and adverse drug reactions of mirabegron versus solifenacin in the treatment of overactive bladder syndrome
by: Megha O. Raj, et al.
Published: (2024-08-01)

Transcutaneous tibial neurostimulation and Solifenacin in urgent incontinence of postmenopausal women
by: Hojjat Radinmehr, et al.
Published: (2023-06-01)

Social, Economic, and Medical Factors Associated With Solifenacin Therapy Compliance Among Workers Who Suffer From Lower Urinary Tract Symptoms
by: Kirill Vladimirovich Kosilov, et al.
Published: (2016-09-01)

Treating overactive bladder symptoms after transurethral prostatic surgery for benign prostatic hyperplasia – Which medication to choose?
by: Cheng-Ling Lee, et al.
Published: (2023-01-01)

Assessment of Anticholinergic Use After Fading of BTX-A Effects in Refractory Idiopathic Overactive Bladder: A Prospective Blinded Randomized Trial
by: M.A. Elbaset, et al.
Published: (2019-09-01)

A retrospective study of treatment persistence and adherence to mirabegron versus antimuscarinics, for the treatment of overactive bladder in Spain
by: Jameel Nazir, et al.
Published: (2018-09-01)

Efficacy and tolerability of mirabegron in female patients with overactive bladder symptoms after surgical treatment for stress urinary incontinence
by: Mete Özkidik, et al.

Effectiveness of Solifenacin versus Mirabegron in the Treatment of Overactive Bladder: A Prospective Cohort Study
by: Shyamali Dutta, et al.
Published: (2025-07-01)

Real life persistence rate with antimuscarinic treatment in patients with idiopathic or neurogenic overactive bladder: a prospective cohort study with solifenacin
by: Marloes J. Tijnagel, et al.
Published: (2017-04-01)

Persistence and compliance with medication management in the treatment of overactive bladder
by: Tae Heon Kim, et al.
Published: (2016-03-01)

Clinical Efficacy of Solifenacin in the Management of Diabetes Mellitus-Associated Versus Idiopathic Overactive Bladder Symptoms: A Multicenter Prospective Study
by: Hoon Choi, et al.
Published: (2018-03-01)

Artificial intelligence-based prediction of treatment failure and medication non-adherence in overactive bladder management
by: Mert Başaranoğlu, et al.
Published: (2025-08-01)

The comparison of outcomes of solifanacin plus behavioral therapy versus Mirabegron alone in management of overactive bladder
by: Muhammad Sajjad, et al.
Published: (2025-09-01)

Efficacy and Safety of Mirabegron Compared to Solifenacin in Treatment of Non-neurogenic Overactive Bladder in Children: A Randomized Controlled Trial
by: Islam Mansour, et al.
Published: (2025-03-01)

Botulinum toxin A for the Treatment of Overactive Bladder
by: Po-Fan Hsieh, et al.
Published: (2016-02-01)

ONABOTULINUM TOXIN-A FOR OVERACTIVE BLADDER
by: Mahmood Shakir Abdulkarim
Published: (2016-12-01)

Overactive bladder
by: Anna Zwierzyńska
Published: (2021-07-01)

Clinical Experience of the Use of Tolterodine in Patients with Overactive Bladder at Siriraj Hospital
by: Vitaya Titapant, et al.
Published: (2020-08-01)

Cerebellar Ataxia and Overactive Bladder after Encephalitis Affecting the Cerebellum
by: Megumi Sugiyama, et al.
Published: (2009-07-01)

Development and validation of the Chinese Overactive Bladder Symptom Score for assessing overactive bladder syndrome in a RESORT study
by: Man-Jung Hung, et al.
Published: (2013-05-01)

Overactive bladder syndrome and bladder wall thickness in patients with obstructive sleep apnea syndrome
by: Zahide Yilmaz, et al.

Overactive Bladder during Pregnancy: A Prospective Longitudinal Study
by: Hung-Ju Chen, et al.
Published: (2022-02-01)

Systematic review and meta-analysis on the association of metabolic syndrome in women with overactive bladder
by: Ana M. Fernández-Alonso, et al.
Published: (2025-12-01)

Childhood nocturnal enuresis and clinical course of overactive bladder in women
by: Igor V. Kuzmin, et al.
Published: (2024-10-01)

Establishment of an overactive bladder model in mice
by: Tengfei Lv, et al.
Published: (2023-02-01)

The Overactive Bladder Symptom Score, International Prostate Symptom Score–Storage Subscore, and Urgency Severity Score in Patients With Overactive Bladder and Hypersensitive Bladder: Which Scoring System is Best?
by: Fei-Chi Chuang, et al.
Published: (2018-06-01)

Clinical and urodynamic effects of tolterodine in women with an overactive bladder
by: Chiu-Lin Wang, et al.
Published: (2013-09-01)

Role of liposome in treatment of overactive bladder and interstitial cystitis
by: Shih-Ya Hung, et al.
Published: (2015-03-01)